MONTREAL--(BUSINESS WIRE)--Genizon BioSciences today announced publication in this week’s Proceedings of the National Academy of Sciences of four novel loci in Crohn’s disease, in addition to confirmation of three known Crohn’s disease genes. These discoveries are derived from a genome-wide association study in the Quebec Founder Population, which provides a unique advantage for comprehensive discovery of disease genes in complex disorders. The new discoveries are expected to lead to the development of novel and more effective treatments for this disease.
